About Shengdar Q. Tsai

Dr. Tsai is an Associate Member in the Department of Hematology at St. Jude Children’s Research Hospital. His research lab focuses on developing genome editing technologies for therapeutics. His group has recently developed CHANGE-seq, a state-of-the-art, sensitive, unbiased, high-throughput method for defining the genome-wide activity of genome editors. Dr. Tsai completed a postdoctoral fellowship at Massachusetts General Hospital & Harvard Medical School, Ph.D. in Functional Genomics and M.S. in Bioinformatics from North Carolina State University. In 2020, he was chosen as one of the American Society for Gene and Cell Therapy Outstanding New Investigators. He is a co-chair of the Steering Committee of the NIH Somatic Cell Genome Editing Consortium.

photo of Shengdar Tsai

Meet the Team

Dreylan Hines
  • Dreylan Hines
  • Researcher
Kasey Jividen, PhD
  • Kasey Jividen, PhD
  • Postdoctoral Research Associate
Varun Katta
  • Varun Katta
  • Scientist
Nikolay Malinin, PhD
  • Nikolay Malinin, PhD
  • Senior Scientist
Azusa Matsubara PhD
  • Azusa Matsubara PhD
  • Scientist
Kiera O’Keefe
  • Kiera O’Keefe
  • Graduate Student
Elizabeth Urbina-Obregon
  • Elizabeth Urbina-Obregon
  • Researcher
Rachael Wood, PhD
  • Rachael Wood, PhD
  • Senior Researcher